These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19135442)

  • 1. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
    Lockrow J; Prakasam A; Huang P; Bimonte-Nelson H; Sambamurti K; Granholm AC
    Exp Neurol; 2009 Apr; 216(2):278-89. PubMed ID: 19135442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
    Hunter CL; Bachman D; Granholm AC
    Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designer receptors enhance memory in a mouse model of Down syndrome.
    Fortress AM; Hamlett ED; Vazey EM; Aston-Jones G; Cass WA; Boger HA; Granholm AC
    J Neurosci; 2015 Jan; 35(4):1343-53. PubMed ID: 25632113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
    Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
    J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ
    Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.
    Hunter CL; Bimonte HA; Granholm AC
    Behav Brain Res; 2003 Jan; 138(2):121-31. PubMed ID: 12527443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
    Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.
    Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
    J Comp Neurol; 2014 Apr; 522(6):1390-410. PubMed ID: 24178831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome.
    Corrales A; Martínez P; García S; Vidal V; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
    J Pineal Res; 2013 Apr; 54(3):346-58. PubMed ID: 23350971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.
    Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O
    Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome.
    Bimonte-Nelson HA; Hunter CL; Nelson ME; Granholm AC
    Behav Brain Res; 2003 Feb; 139(1-2):47-57. PubMed ID: 12642175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.
    Ash JA; Velazquez R; Kelley CM; Powers BE; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2014 Oct; 70():32-42. PubMed ID: 24932939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.
    Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
    Hippocampus; 2018 Apr; 28(4):251-268. PubMed ID: 29394516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.
    Holtzman DM; Santucci D; Kilbridge J; Chua-Couzens J; Fontana DJ; Daniels SE; Johnson RM; Chen K; Sun Y; Carlson E; Alleva E; Epstein CJ; Mobley WC
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13333-8. PubMed ID: 8917591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
    Seo H; Isacson O
    Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.